IL144583A0
(en)
*
|
2001-07-26 |
2002-05-23 |
Peptor Ltd |
Chimeric protein kinase inhibitors
|
CA2480880C
(en)
|
2002-04-08 |
2011-03-22 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
WO2003086394A1
(en)
*
|
2002-04-08 |
2003-10-23 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
CA2501365C
(en)
*
|
2002-10-30 |
2011-05-31 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
KR101251624B1
(ko)
|
2003-04-18 |
2013-04-08 |
가부시키가이샤 한도오따이 에네루기 켄큐쇼 |
퀴녹살린 유도체, 그것을 이용한 유기 반도체 소자 및 전계 발광 소자
|
CN1809351A
(zh)
|
2003-04-24 |
2006-07-26 |
麦克公司 |
Akt活性抑制剂
|
CA2522431A1
(en)
*
|
2003-04-24 |
2004-11-11 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
AU2004233826B2
(en)
|
2003-04-24 |
2009-08-13 |
Merck Sharp & Dohme Corp. |
Inhibitors of Akt activity
|
US7414055B2
(en)
|
2003-04-24 |
2008-08-19 |
Merck & Co., Inc. |
Inhibitors of Akt activity
|
IL156429A0
(en)
*
|
2003-06-12 |
2004-01-04 |
Peptor Ltd |
Cell permeable conjugates of peptides for inhibition of protein kinases
|
JP2007532551A
(ja)
*
|
2004-04-09 |
2007-11-15 |
メルク エンド カムパニー インコーポレーテッド |
Akt活性の阻害剤
|
CA2561311A1
(en)
*
|
2004-04-09 |
2005-10-27 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
EP1784175A4
(de)
*
|
2004-08-23 |
2009-07-22 |
Merck & Co Inc |
Inhibitoren von akt-aktivität
|
CN101242834A
(zh)
|
2004-12-15 |
2008-08-13 |
默克公司 |
Akt活性抑制剂
|
US8362075B2
(en)
|
2005-05-17 |
2013-01-29 |
Merck Sharp & Dohme Corp. |
Cyclohexyl sulphones for treatment of cancer
|
PT1898903E
(pt)
|
2005-06-10 |
2013-06-28 |
Merck Sharp & Dohme |
Inibidores da atividade de akt
|
WO2007032258A1
(en)
*
|
2005-09-12 |
2007-03-22 |
Semiconductor Energy Laboratory Co., Ltd. |
Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same
|
EP1978964A4
(de)
|
2006-01-24 |
2009-12-09 |
Merck & Co Inc |
Jak2-tyrosinkinase-hemmung
|
GB0603041D0
(en)
|
2006-02-15 |
2006-03-29 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
WO2007108403A1
(en)
*
|
2006-03-21 |
2007-09-27 |
Semiconductor Energy Laboratory Co., Ltd. |
Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative
|
CA2664113C
(en)
|
2006-09-22 |
2013-05-28 |
Merck & Co., Inc. |
Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer
|
US20100022573A1
(en)
*
|
2006-12-06 |
2010-01-28 |
Layton Mark E |
Inhibitors of akt activity
|
AR064010A1
(es)
*
|
2006-12-06 |
2009-03-04 |
Merck & Co Inc |
Inhibidores de la actividad de la akt
|
AU2007340129B2
(en)
|
2006-12-26 |
2012-02-02 |
Pharmacyclics Llc |
Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
|
PL2805945T3
(pl)
|
2007-01-10 |
2019-09-30 |
Msd Italia S.R.L. |
Indazole podstawione grupą amidową jako inhibitory polimerazy poli(adp-rybozy) - (parp)
|
US8178216B2
(en)
*
|
2007-02-28 |
2012-05-15 |
Semiconductor Energy Laboratory Co., Ltd. |
Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative
|
KR101514853B1
(ko)
|
2007-03-01 |
2015-04-24 |
노파르티스 아게 |
Pim 키나제 억제제 및 이들의 사용 방법
|
ES2452349T3
(es)
|
2007-05-21 |
2014-04-01 |
Novartis Ag |
Inhibidores de CSF-1R, composiciones, y métodos de uso
|
AR066879A1
(es)
*
|
2007-06-08 |
2009-09-16 |
Novartis Ag |
Derivados de quinoxalina como inhibidores de la actividad de cinasa de tirosina de las cinasas janus
|
WO2009002495A1
(en)
|
2007-06-27 |
2008-12-31 |
Merck & Co., Inc. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
EP2067778B1
(de)
*
|
2007-12-03 |
2016-08-17 |
Semiconductor Energy Laboratory Co., Ltd. |
Quinoxalin-Derivat und lichtemittierendes Element, lichtemittierende Vorrichtung und elektronische Vorrichtung damit
|
JP5574598B2
(ja)
*
|
2007-12-03 |
2014-08-20 |
株式会社半導体エネルギー研究所 |
キノキサリン誘導体、およびキノキサリン誘導体を用いた発光素子、発光装置、電子機器
|
WO2009148916A1
(en)
*
|
2008-06-03 |
2009-12-10 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
MX2010013224A
(es)
*
|
2008-06-03 |
2010-12-21 |
Merck Sharp & Dohme |
Inhibidores de la actividad de la serina/treonina cinasa.
|
CA2750051A1
(en)
*
|
2009-02-02 |
2010-08-05 |
Merck Sharp & Dohme Corp. |
Inhibitors of akt activity
|
CA2752150A1
(en)
*
|
2009-02-11 |
2010-08-19 |
Reaction Biology Corp. |
Selective kinase inhibitors
|
US8168652B2
(en)
|
2009-03-12 |
2012-05-01 |
Merck Sharp & Dohme Corp. |
Inhibitors of AKT activity
|
WO2010114780A1
(en)
|
2009-04-01 |
2010-10-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of akt activity
|
UA109417C2
(uk)
|
2009-10-14 |
2015-08-25 |
Мерк Шарп Енд Доме Корп. |
ЗАМІЩЕНІ ПІПЕРИДИНИ, ЯКІ ПІДВИЩУЮТЬ АКТИВНІСТЬ p53, І ЇХ ЗАСТОСУВАННЯ
|
WO2011075515A1
(en)
|
2009-12-17 |
2011-06-23 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
US8999957B2
(en)
|
2010-06-24 |
2015-04-07 |
Merck Sharp & Dohme Corp. |
Heterocyclic compounds as ERK inhibitors
|
US8518907B2
(en)
|
2010-08-02 |
2013-08-27 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
|
EP4079856A1
(de)
|
2010-08-17 |
2022-10-26 |
Sirna Therapeutics, Inc. |
Rna-interferenz-vermittelte hemmung der hepatitis b-virus (hbv)-genexpression mittels kurzer interferierender nukleinsäure (sina)
|
EP2608669B1
(de)
|
2010-08-23 |
2016-06-22 |
Merck Sharp & Dohme Corp. |
Neue pyrazolo-[1,5-a-]pyrimidinderivate als mtor-hemmer
|
US8946216B2
(en)
|
2010-09-01 |
2015-02-03 |
Merck Sharp & Dohme Corp. |
Indazole derivatives useful as ERK inhibitors
|
US9242981B2
(en)
|
2010-09-16 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
Fused pyrazole derivatives as novel ERK inhibitors
|
WO2012058210A1
(en)
|
2010-10-29 |
2012-05-03 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
|
WO2012087772A1
(en)
|
2010-12-21 |
2012-06-28 |
Schering Corporation |
Indazole derivatives useful as erk inhibitors
|
CA2833009A1
(en)
|
2011-04-21 |
2012-10-26 |
Merck Sharp & Dohme Corp. |
Insulin-like growth factor-1 receptor inhibitors
|
EP2548877A1
(de)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Gliedrige kondensierte Pyridinyl)benzamide als BTK-Inhibitoren
|
ES2725790T3
(es)
|
2011-08-26 |
2019-09-27 |
Neupharma Inc |
Algunas entidades químicas, composiciones, y métodos
|
JP6093768B2
(ja)
|
2011-09-14 |
2017-03-08 |
ニューファーマ, インコーポレイテッド |
特定の化学的実体、組成物、および方法
|
US9249110B2
(en)
|
2011-09-21 |
2016-02-02 |
Neupharma, Inc. |
Substituted quinoxalines as B-raf kinase inhibitors
|
US9249111B2
(en)
|
2011-09-30 |
2016-02-02 |
Neupharma, Inc. |
Substituted quinoxalines as B-RAF kinase inhibitors
|
US9023865B2
(en)
|
2011-10-27 |
2015-05-05 |
Merck Sharp & Dohme Corp. |
Compounds that are ERK inhibitors
|
US9408885B2
(en)
|
2011-12-01 |
2016-08-09 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
US9670180B2
(en)
|
2012-01-25 |
2017-06-06 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
WO2013165816A2
(en)
|
2012-05-02 |
2013-11-07 |
Merck Sharp & Dohme Corp. |
SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
|
WO2013192088A1
(en)
|
2012-06-22 |
2013-12-27 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
EP2863916B1
(de)
|
2012-06-22 |
2018-07-18 |
Merck Sharp & Dohme Corp. |
Substituierte pyridin-milz-tyrosinkinaseinhibitoren
|
US9688635B2
(en)
|
2012-09-24 |
2017-06-27 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
MX2015004041A
(es)
|
2012-09-28 |
2015-07-06 |
Merck Sharp & Dohme |
Compuestos novedosos que son inhibidores de erk.
|
WO2014075077A1
(en)
|
2012-11-12 |
2014-05-15 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
CA2892361A1
(en)
|
2012-11-28 |
2014-06-05 |
Merck Sharp & Dohme Corp. |
Use of a wee1 inhibitor for treating a cancer characterized by low pkmyt1 expression levels
|
RU2690663C2
(ru)
|
2012-12-20 |
2019-06-05 |
Мерк Шарп И Доум Корп. |
Замещенные имидазопиридины в качестве ингибиторов hdm2
|
US20140206681A1
(en)
|
2013-01-23 |
2014-07-24 |
Ronald M. Kim |
Btk inhibitors
|
WO2014113942A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2014120748A1
(en)
|
2013-01-30 |
2014-08-07 |
Merck Sharp & Dohme Corp. |
2,6,7,8 substituted purines as hdm2 inhibitors
|
AU2014214326B2
(en)
|
2013-02-07 |
2018-07-05 |
Prexton Therapeutics Sa |
Substituted quinoxaline derivatives and their use as positive allosteric modulators of mGluR4
|
EP2988749B1
(de)
|
2013-04-26 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
Thiazolsubstituierte aminopyridine als milztyrosinkinasehemmer
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
WO2015095102A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
EP3083560B1
(de)
|
2013-12-20 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Thiazolsubstituierte aminoheteroaryle als milztyrosinkinasehemmer
|
US9637486B2
(en)
|
2013-12-20 |
2017-05-02 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
JO3589B1
(ar)
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
WO2016106624A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Tertiary alcohol imidazopyrazine btk inhibitors
|
WO2016106626A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Imidazopyrazine analogs with 3-tertiary carbon substitutions as btk inhibitors
|
WO2016106623A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Benzamide imidazopyrazine btk inhibitors
|
WO2016106629A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106628A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
US10045981B2
(en)
|
2015-11-24 |
2018-08-14 |
Jakpharm, Llc |
Selective kinase inhibitors
|
JOP20190055A1
(ar)
|
2016-09-26 |
2019-03-24 |
Merck Sharp & Dohme |
أجسام مضادة ضد cd27
|
SG11201908813QA
(en)
|
2017-04-13 |
2019-10-30 |
Aduro Biotech Holdings Europe B V |
Anti-sirp alpha antibodies
|
EP3706742B1
(de)
|
2017-11-08 |
2023-03-15 |
Merck Sharp & Dohme LLC |
Prmt5-inhibitoren
|
WO2019148412A1
(en)
|
2018-02-01 |
2019-08-08 |
Merck Sharp & Dohme Corp. |
Anti-pd-1/lag3 bispecific antibodies
|
JP7162372B2
(ja)
|
2018-07-02 |
2022-10-28 |
深▲チェン▼市塔吉瑞生物医薬有限公司 |
キナーゼ活性を阻害するためのアルキニル(ヘテロ)芳香族化合物
|
CN110272426B
(zh)
|
2018-07-17 |
2022-05-31 |
深圳市塔吉瑞生物医药有限公司 |
用于抑制蛋白激酶活性的炔基(杂)芳环类化合物
|
WO2020033282A1
(en)
|
2018-08-07 |
2020-02-13 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
EP3833667B1
(de)
|
2018-08-07 |
2024-03-13 |
Merck Sharp & Dohme LLC |
Prmt5-inhibitoren
|
CN109518211B
(zh)
*
|
2019-01-08 |
2020-11-06 |
合肥工业大学 |
一种芳香偶酰类化合物的电化学合成方法
|
CN115087638B
(zh)
|
2019-12-17 |
2023-11-24 |
默沙东公司 |
Prmt5抑制剂
|